Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 38.75 | 30.29 |
| PEG Ratio (TTM) | -7.49 | -0.29 |
| P/S Ratio (TTM) | 2.67 | 3.55 |
| P/B Ratio (TTM) | 3.87 | 31.78 |
| P/FCF Ratio (TTM) | 29.46 | 24.81 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.61 |
| Price to 5YR AVG FCF Ratio | N/A | 24.43 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.95% | 10.83% |
| ROE (TTM) | 9.98% | 118.76% |
| Net Profit Margin (TTM) | 6.88% | 13.03% |
| ROIC 5YR AVG | N/A | 26.41% |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 110.60% | 55.98% | N/A |
| Revenue | 0.01% | 1.46% | N/A |
| Net Income | 111.28% | 58.16% | N/A |
| Cash Flow | -4.74% | 193.04% | N/A |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.00 | 0.91 |
| Quick Ratio (TTM) | 0.69 | 0.64 |
| D/E Ratio (TTM) | 0.82 | 3.87 |
| Interest Coverage (TTM) | 6.76 | 15.03 |
| Piotroski F-Score | 8 | 8 |
| Altman Z-Score | 2.32 | 5.30 |
| LTL to 5YR AVG FCF | N/A | 4.38 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.20% |